Antibody Drug Conjugates Global Market Share, Segmentation, Opportunities and Forecast to 2021

Report Scope:

Antibody drug conjugates are mainly used to treat cancer and are safer and more effective than many other cancer therapies. This report focuses on the global market for antibody drug conjugate products and provides an updated review, including their basic design and application in various areas of the biomedical sciences. The report covers three main areas of application, breast cancer, lymphoma and other cancers, including acute myeloid leukemia. The scope of this study includes the current market for ADCs. The report also discusses regulatory aspects, current and developing technologies, market projections and market shares. An analysis of clinical trials, innovations and opportunities and the latest trends in ADC market are also discussed in the report.

 

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2820095-antibody-drug-conjugates-technologies-and-global-markets          

 

Also included in the report is an analysis of relevant patents and profiles of companies that lead the antibody drug conjugate product market. Seattle Genetics Inc., Takeda Pharmaceuticals Co. Ltd. and Genentech Inc. are the major players in the market for ADCs at present.

 

Sales data for the global and regional markets were corroborated for the present and forecasted values via statistical analysis, and sales are broken down geographically into North America, Europe, Asia-Pacific and the emerging markets. The application of ADCs in various types of cancer is discussed from both a commercial perspective and that of a research and development (R&D) perspective.

 

The report only covers antibody drug conjugates in which an antibody is conjugated with small-molecule cytotoxins (payload) through a linker. ADCs are a form of antibody conjugates. Other forms of antibody conjugates such as radioisotope conjugated with an antibody are beyond the scope of this report. The study also does not cover mAbs that do not contain a linker and cytotoxic agent and, thus, do not constitute an ADC.

 

Report Includes:

- An overview of the global market for antibody drug conjugates as a part of the pharmaceutical industry that is looking for innovative technologies.

- Analyses of global market trends, with data from 2014, 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.

- Examination of key market drivers and challenges.

- Insight into regulatory hurdles and how to meet them, as well as discussion of the drugs (and the companies behind them) that have received approval.

 

Key Players

ABBVIE INC.

ABGENOMICS INTERNATIONAL INC.

ABZENA PLC

ADC BIOTECHNOLOGY LTD.

ADC THERAPEUTICS SA

AFFINICON APS

AGENSYS INC.

AMBRX INC.

AMGEN INC.

ANTIKOR BIOPHARMA LTD.

ASTELLAS PHARMA U.S. INC.

ASTRAZENECA PLC

BAYER AG

BIOTEST AG

CATALENT PHARMA SOLUTIONS

CELLDEX THERAPEUTICS INC.

CELLTRION

CENTROSE

CYTOMX THERAPEUTICS INC.

DAIICHI SANKYO CO. LTD.

DALTON PHARMA SERVICES

ELI LILLY AND CO.

ESPERANCE PHARMACEUTICALS INC.

1. HOFFMANN-LA-ROCHE AG (ROCHE)

FORMATION BIOLOGICS

GENMAB A/S

GLAXOSMITHKLINE PLC

HEIDELBERG PHARMA GMBH

IMMUNOGEN INC.

IMMUNOMEDICS INC.

MERSANA THERAPEUTICS INC.

MILLENNIUM PHARMACEUTICALS INC. (NOW TAKEDA ONCOLOGY)

MORPHOSYS AG

NBE THERAPEUTICS

OXFORD BIOTHERAPEUTICS

PFIZER INC.

PHILOGEN SPA

PIERRE FABRE

PROGENICS PHARMACEUTICALS INC.

SANOFI

SEATTLE GENETICS INC.

SEVION THERAPEUTICS

SORRENTO THERAPEUTICS INC.

SUTRO BIOPHARMA INC.

SYNTHON BV

VIVENTIA BIOTECHNOLOGIES INC.

ZHEJIANG MEDICINE CO. LTD.

 

Table of Content: Key Points

Chapter 1 Introduction

Study Goals and Objectives

Reasons for Doing This Study

Scope of Report

Information Sources

Methodology

Geographic Breakdown

Analyst's Credentials

Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Chapter 4 Market Breakdown by Technology Type

Chapter 5 Market Breakdown by Application

Chapter 6 Industry Structure

Chapter 7 Market Breakdown by Region

Chapter 8 Patent Review/New Developments

Chapter 9 Analysis of Market Opportunities

Chapter 10 Company Profiles

…Continued                            

 

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2820095-antibody-drug-conjugates-technologies-and-global-markets     

                                 

Contact Info:                                                         

NORAH TRENT                                                      

[email protected]             

Ph: +1-646-845-9349 (US)                          

Ph: +44 208 133 9349 (UK)                                                   

                                                                             

Get in touch:                                                         

LinkedIn: www.linkedin.com/company/4828928

Twitter: https://twitter.com/WiseGuyReports                                                                  

Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts